Evidence map›Paper›PMID 34152246›Full record

SynthesisLupus2021

Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort study.

Aline L Meier, Nicolas S Bodmer, Carla Wirth, Lucas M Bachmann, Camillo Ribi, Anne-Katrin Pröbstel, David Waeber, Ilijas Jelcic, Urs C Steiner, Swiss SLE Cohort Study (SSCS)

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Lupus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Epidemiology of systemic lupus erythematosus in Korea.Journal of rheumatic diseases · 2023
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aline L MeierDepartment of Immunology, University Hospital of Zurich, Zurich, Switzerland.ORCID https://orcid.org/0000-0003-0698-711X
Nicolas S BodmerMedignition Healthcare Innovations, Zurich, Switzerland.
Carla WirthMedignition Healthcare Innovations, Zurich, Switzerland.
Lucas M BachmannMedignition Healthcare Innovations, Zurich, Switzerland.
Camillo RibiDivision of Immunology and Allergy, Lausanne University Hospital, Lausanne, Switzerland.
Anne-Katrin PröbstelNeurologic Clinic and Policlinic, Departments of Medicine and Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
David WaeberDepartement of Psychiatry, University Hospital of Zurich, Zurich, Switzerland.
Ilijas JelcicDepartement of Neurology, University Hospital of Zurich, Zurich, Switzerland.
Urs C SteinerDepartment of Immunology, University Hospital of Zurich, Zurich, Switzerland.
Swiss SLE Cohort Study (SSCS)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesSystemic lupus erythematosus (SLE) is a systemic autoimmune disease associated with neuro-psychiatric (NP) manifestations. Frequency and patterns of neuro-psychiatric systemic lupus erythematosus (NPSLE) vary substantially between patients. We conducted a systematic review (SR) of the literature and examined prevalence and characteristics of NPSLE in the Swiss SLE cohort study (SSCS).

methodsThe SR search was performed between January 1999 and January 2020. We included prospective/cross-sectional studies focusing on NPSLE. We secured study characteristics, cohort compositions and frequencies of NP manifestations, assessed heterogeneity across reports and investigated sources of variation using meta-regression models. Regarding the SSCS, we reviewed all patients included and classified NP manifestations.

resultsThe SR searches identified 530 studies. We included 22 studies in our meta-analysis, the mean frequency of NPSLE ranged from 10.6% to 96.4%. The frequency of NPSLE in the SSCS was 28.1%. Severe events including cerebrovascular insults, seizures and psychosis appeared in 7.1%, 5.3% and 6.5% respectively. There was a linear relationship between duration of SLE and cumulative incidence of NPSLE.

conclusionsThe spectrum of NPSLE is very broad. The diagnostic work-up and rates of reported manifestations varied substantially across studies. We call for concerted efforts and consensus regarding definitions of NPSLE that will facilitate accurate diagnosis and attribution to SLE, particularly with a view to timely intervention and patient outcomes.

Indexed as

Lupus Erythematosus, DiscoidLupus Erythematosus, SystemicLupus Vasculitis, Central Nervous SystemCohort StudiesCross-Sectional StudiesHumansProspective StudiesSwitzerlandmeta-analysisneuropsychiatricNPSLEprevalenceSSCSSystemic lupus erythematosus

Identifiers

PMID34152246
PMCPMC8489688

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.